BN Danone SA

Danone: Information on the total number of voting rights and shares

Danone: Information on the total number of voting rights and shares

DANONE

French Société anonyme with a capital of €169,443,282,00.

Registered Office: 17, boulevard Haussmann, 75009 Paris.

Registered with the Paris Commerce and Company Registry under number 552 032 534

Information on the total number of voting rights and shares

in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers)

DateTotal number of sharesTotal number of voting rights




31/03/2024



677,773,128



Total number of theoretical voting rights(1) : 698,774,274







Total number of exercisable voting rights(2) : 662,873,028







(1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended.

(2) The total number of exercisable voting rights (or ”net” voting rights) is calculated without taking into account the shares with suspended voting rights. It is published to ensure that the public is properly informed in accordance with the recommendation made by the AMF on July 17, 2007.

 

Attachment



EN
18/04/2024

Underlying

BNDanone SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Danone SA

 PRESS RELEASE
Free
BN DANONE SA

Danone acquires Functional Formularies

Danone acquires Functional Formularies Press release – Paris, May 01, 2024 Danone acquires Functional Formularies Danone announces today it has successfully completed the acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital. As part of the Renew Danone strategy, this acquisition strengthens Danone’s Medical Nutrition portfolio in the US by further expanding its enteral tube feeding ranges. Juergen Esser, Deputy CEO and CFO, said: “As a global leader in Medical Nutrition, we are delighted to welcome Functional Formularie...

2h / 45m 1 EN
 PRESS RELEASE
Free
BN DANONE SA

Danone acquiert Functional Formularies

Danone acquiert Functional Formularies Communiqué de presse – Paris, le 1er mai 2024 Danone acquiert Functional Formularies Danone annonce aujourd’hui avoir réalisé l’acquisition de Functional Formularies, leader aux Etats-Unis de l’alimentation par sonde à base d’aliments, auprès de Swander Pace Capital. Dans le cadre de la stratégie Renew Danone, cette acquisition renforce le portefeuille de Danone en Nutrition Médicale aux Etats-Unis, élargissant sa gamme d’alimentation entérale. Juergen Esser, Directeur Général Adjoint et Directeur Financier : « Nous sommes ravis d'accueillir Funct...

2h / 45m 1 EN
 PRESS RELEASE
Free
BN DANONE SA

Danone successfully issues a €700 million bond

Danone successfully issues a €700 million bond Press Release – Paris, April 26, 2024 Danone successfully issues a €700 million bond Danone announces that it has issued today a €700 million bond with a 6-year maturity and a 3.481% coupon. In line with the company’s active liquidity management, this issue enables Danone to enhance its funding flexibility while extending the maturity of its debt. The settlement is expected to take place on May 3, 2024 and the bonds will be listed on Euronext Paris. The bond issue was widely subscribed by a diversified investor base, confirming the high c...

April 26, 2024 1 EN
 PRESS RELEASE
Free
BN DANONE SA

Danone réalise avec succès une émission obligataire de 700 millions d’...

Danone réalise avec succès une émission obligataire de 700 millions d’euros Communiqué de presse – Paris, le 26 avril 2024 Danone réalise avec succès une émission obligataire de 700 millions d’euros Danone annonce avoir réalisé aujourd’hui le placement d’une émission obligataire d’un montant de 700 millions d’euros, avec une maturité de 6 ans et assortie d’un coupon de 3,481%. S’inscrivant dans le cadre de la gestion active de sa liquidité, cette émission permet à Danone d’accroître sa flexibilité financière tout en allongeant la maturité de sa dette. Le règlement-livraison est prévu le...

April 26, 2024 1 EN
 PRESS RELEASE
Free
BN DANONE SA

Danone: 2024 Danone Shareholders’ Meeting: approval of all resolutions

Danone: 2024 Danone Shareholders’ Meeting: approval of all resolutions Press Release – Paris, April 25, 2024 2024 Danone Shareholders’ Meeting: approval of all resolutions Danone’s Shareholders’ Meeting was held today, chaired by Gilles Schnepp, Chairman of the Board of Directors. 73.58% of Danone’s total outstanding share capital was present or represented in this Shareholders’ Meeting. Danone’s shareholders approved all resolutions submitted to its approval by the Board of Directors, including the statutory and consolidated financial statements for the 2023 fiscal year, and the distri...

April 25, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch